NO994631D0 - Fremgangsmaater og sammensetninger for behandling av eggstokkreft - Google Patents

Fremgangsmaater og sammensetninger for behandling av eggstokkreft

Info

Publication number
NO994631D0
NO994631D0 NO994631A NO994631A NO994631D0 NO 994631 D0 NO994631 D0 NO 994631D0 NO 994631 A NO994631 A NO 994631A NO 994631 A NO994631 A NO 994631A NO 994631 D0 NO994631 D0 NO 994631D0
Authority
NO
Norway
Prior art keywords
procedures
compositions
treatment
ovarian cancer
ovarian
Prior art date
Application number
NO994631A
Other languages
English (en)
Other versions
NO994631L (no
Inventor
Karl L Mettinger
Original Assignee
Baker Norton Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baker Norton Pharma filed Critical Baker Norton Pharma
Publication of NO994631D0 publication Critical patent/NO994631D0/no
Publication of NO994631L publication Critical patent/NO994631L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO994631A 1997-03-27 1999-09-23 Fremgangsmåter og preparater for behandling av eggstokkreft NO994631L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4162897P 1997-03-27 1997-03-27
PCT/US1998/006232 WO1998042330A1 (en) 1997-03-27 1998-03-27 Methods and compositions for treatment of ovarian cancer

Publications (2)

Publication Number Publication Date
NO994631D0 true NO994631D0 (no) 1999-09-23
NO994631L NO994631L (no) 1999-11-23

Family

ID=21917518

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994631A NO994631L (no) 1997-03-27 1999-09-23 Fremgangsmåter og preparater for behandling av eggstokkreft

Country Status (11)

Country Link
US (1) US6334445B1 (no)
EP (1) EP1007029A4 (no)
JP (1) JP2001524963A (no)
KR (1) KR20010005740A (no)
CN (1) CN1254279A (no)
AU (1) AU744095B2 (no)
CA (1) CA2285391A1 (no)
IL (1) IL132094A0 (no)
NO (1) NO994631L (no)
PL (1) PL335891A1 (no)
WO (1) WO1998042330A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2326485C (en) * 1998-04-01 2008-12-09 Rtp Pharma Inc. Anticancer compositions
WO1999065531A1 (en) 1998-06-18 1999-12-23 Johns Hopkins University School Of Medicine Polymers for delivery of nucleic acids
US6350464B1 (en) 1999-01-11 2002-02-26 Guilford Pharmaceuticals, Inc. Methods for treating ovarian cancer, poly (phosphoester) compositions, and biodegradable articles for same
US6537585B1 (en) 1999-03-26 2003-03-25 Guilford Pharmaceuticals, Inc. Methods and compositions for treating solid tumors
DE10244847A1 (de) * 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medizinische Vorrichtung zur Arzneimittelabgabe
JP2006514698A (ja) * 2002-10-30 2006-05-11 スフェリックス， インコーポレイテッド ナノ粒子生物活性物質
CA2623445A1 (en) * 2005-09-21 2007-03-29 Ccc Diagnostics, Llc Comprehensive diagnostic testing procedures for personalized anticancer chemotherapy (pac)
PT2155188E (pt) * 2007-06-01 2013-12-19 Abraxis Bioscience Llc Métodos e composições para o tratamento de cancro recorrente
CN102970990A (zh) 2010-05-03 2013-03-13 帝国制药美国公司 非水性紫杉烷前-乳剂制剂以及制备和使用该制剂的方法
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
CN103432141A (zh) * 2013-08-29 2013-12-11 南京大学 Chukrasone A在治疗卵巢癌药物中的应用
WO2017066786A1 (en) * 2015-10-16 2017-04-20 Carefusion 303, Inc. Readmission risk scores

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5620875A (en) * 1995-02-17 1997-04-15 University Of Portland Transfer of taxol from yew tree cuttings into a culture medium over time

Also Published As

Publication number Publication date
WO1998042330A1 (en) 1998-10-01
EP1007029A4 (en) 2003-03-26
EP1007029A1 (en) 2000-06-14
CN1254279A (zh) 2000-05-24
KR20010005740A (ko) 2001-01-15
US6334445B1 (en) 2002-01-01
AU744095B2 (en) 2002-02-14
PL335891A1 (en) 2000-05-22
CA2285391A1 (en) 1998-10-01
NO994631L (no) 1999-11-23
AU6787498A (en) 1998-10-20
IL132094A0 (en) 2001-03-19
JP2001524963A (ja) 2001-12-04

Similar Documents

Publication Publication Date Title
NO971015L (no) Forbindelser og metoder for behandling av cancer
NO991700D0 (no) Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer
NO994778D0 (no) FremgangsmÕter og sammensetninger for behandling av tarmbetennelse
PL349322A1 (en) Compositions and methods for therapy and diagnosis of ovarian cancer
NO20003096L (no) Sammensetninger og fremgangsmÕter for behandling av ADD
IL189132A0 (en) Pharmaceutical compositions for the treatment of prostate hypertrophy and prostate cancer
DK1813624T3 (da) Fremgangsmåder og sammensætninger til forebyggelse og behandling af anæmi
NO20015516L (no) Preparater og anvendelser av ET743 for behandling av kreft
ATE239509T1 (de) Konjugate zur behandlung von prostatakrebs
NO20012963L (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
IL136110A0 (en) Methods and compositions for the treatment of psoriasis
NO20002189L (no) Anvendelse av makrolider for behandling av cancer og mukuladegenerasjon
NO994631D0 (no) Fremgangsmaater og sammensetninger for behandling av eggstokkreft
DE69836209D1 (de) Vorbeugung und behandlunhg des hepatozellulären krebses
NO20054619D0 (no) Sammensetninger og fremgangsmater for behandling av underjordiske formasjoner
PT102054A (pt) Composicao para o tratamento de sementes de arroz
IL141426A0 (en) Compositions and methods for the treatment of tumor
EP1349485A4 (en) COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF OVARIAL CARCINOMA
PL368035A1 (en) Compositions and methods for the treatment of cancer
DK1079818T3 (da) Præparat omfattende IL-18 og topotecan til behandling og/eller forhindring af cancer
NO20001758D0 (no) Fremgangsmåter og blandinger for behandling av leddgikt
IL143212A0 (en) Compositions and methods for the treatment of tumor
AU3483001A (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
NO981662L (no) Diagnosering av disponerhet for kreft og behandling av dette
NO20012099D0 (no) Fremgangsmåte for fremstilling av 4-arylpiperidin-3- carbinoler og beslektede forbindelser